Erasca, INC.(ERAS)

盘后15.24-0.26-1.68%19:58 EDT

15.50-0.08-0.51%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Erasca与Tango Therapeutics达成临床合作，评估ERAS-0015与Vopimetostat联合疗法
  美股速递 · 03-05
  Erasca与Tango Therapeutics达成临床合作，评估ERAS-0015与Vopimetostat联合疗法
- Erasca, Inc.盘中异动下午盘股价大涨5.05%
  市场透视 · 01-28
  Erasca, Inc.盘中异动下午盘股价大涨5.05%
- Erasca, Inc.盘中异动早盘股价大涨5.30%
  市场透视 · 01-20
  Erasca, Inc.盘中异动早盘股价大涨5.30%
- Erasca, Inc.盘中异动早盘股价大跌5.18%
  市场透视 · 01-12
  Erasca, Inc.盘中异动早盘股价大跌5.18%
- Erasca, Inc.盘中异动早盘大幅上涨5.07%
  市场透视 · 2025-12-22
  Erasca, Inc.盘中异动早盘大幅上涨5.07%
- Erasca第三季度基本每股收益为-0.11美元
  投资观察 · 2025-11-20
  Erasca第三季度基本每股收益为-0.11美元
- Erasca, Inc.盘中异动早盘股价大涨5.02%报2.41美元
  市场透视 · 2025-11-11
  Erasca, Inc.盘中异动早盘股价大涨5.02%报2.41美元
- Erasca, Inc.盘中异动早盘大幅跳水5.37%
  市场透视 · 2025-11-04
  Erasca, Inc.盘中异动早盘大幅跳水5.37%
- Erasca, Inc.盘中异动股价大涨5.08%
  市场透视 · 2025-10-30
  Erasca, Inc.盘中异动股价大涨5.08%
- Erasca, Inc.盘中异动急速跳水5.04%
  市场透视 · 2025-10-22
  Erasca, Inc.盘中异动急速跳水5.04%
- Erasca, Inc.盘中异动早盘股价大涨5.22%
  市场透视 · 2025-10-16
  Erasca, Inc.盘中异动早盘股价大涨5.22%
- Erasca, Inc.盘中异动急速拉升5.36%报2.46美元
  市场透视 · 2025-10-08
  Erasca, Inc.盘中异动急速拉升5.36%报2.46美元
- Erasca, Inc.盘中异动股价大涨5.05%报2.29美元
  市场透视 · 2025-10-02
  Erasca, Inc.盘中异动股价大涨5.05%报2.29美元
- Erasca, Inc.盘中异动快速上涨5.06%
  市场透视 · 2025-09-24
  Erasca, Inc.盘中异动快速上涨5.06%
- Erasca, Inc.盘中异动股价大跌5.23%
  市场透视 · 2025-03-11
  Erasca, Inc.盘中异动股价大跌5.23%
- Erasca, Inc.盘中异动下午盘股价大涨6.82%
  市场透视 · 2025-03-06
  Erasca, Inc.盘中异动下午盘股价大涨6.82%
- Erasca, Inc.盘中异动大幅跳水5.11%报1.30美元
  市场透视 · 2025-03-03
  Erasca, Inc.盘中异动大幅跳水5.11%报1.30美元
- Erasca, Inc.盘中异动早盘股价大涨5.04%报1.36美元
  市场透视 · 2025-02-28
  Erasca, Inc.盘中异动早盘股价大涨5.04%报1.36美元
- Erasca, Inc.盘中异动下午盘快速下挫5.04%
  市场透视 · 2025-02-28
  Erasca, Inc.盘中异动下午盘快速下挫5.04%
- Erasca, Inc.盘中异动下午盘急速下跌5.32%报1.34美元
  市场透视 · 2025-02-26
  Erasca, Inc.盘中异动下午盘急速下跌5.32%报1.34美元
公司概况
公司名称
Erasca, INC.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.erasca.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Erasca, Inc.于2018年7月2日在特拉华州注册成立。该公司是一家临床阶段的精准肿瘤学公司，专注于发现、开发和商业化RAS/MAPK通路驱动癌症患者的疗法。该公司由精准肿瘤学和RAS靶向领域的领先先驱共同创立，旨在创造新的疗法和联合方案，旨在全面关闭RAS/MAPK通路以治疗癌症。
- 03-04
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 02-17
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 01-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-22
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-15
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 01-12
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-07
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-12-15
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-17
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-13
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-10-15
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-15
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-08-21
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence

分时
5日
日
周
月

数据加载中...

最高

15.77

今开

15.40

量比

0.95

最低

15.22

昨收

15.58

换手率

2.14%

Erasca, INC.(ERAS)

公司概况

热议股票